JP2003510349A

JP2003510349A - 線条体機能に必要な遺伝子、その使用、およびそれを調節するための化合物

線条体機能に必要な遺伝子、その使用、およびそれを調節するための化合物

Info

Publication number: JP2003510349A
Authority: JP; Japan
Prior art keywords: pde10a; disease; expression; sequence; cag
Prior art date: 1999-10-07
Legal status : Pending

Application number

JP2001527780A

Other languages

English (en)

Japanese (ja)

Inventor

ハロルド，エー．ロバートソン

デノヴァン−ライト，アイリーン，エム．

Original Assignee

ノヴァ−ニューロンインコーポレーテッド

Priority date

1999-10-07

Filing date

2000-10-06

Publication date

2003-03-18

1999-10-07 Priority claimed from CA 2285690 external-priority patent/CA2285690A1/fr

2000-10-06 Application filed by ノヴァ−ニューロンインコーポレーテッド filed Critical ノヴァ−ニューロンインコーポレーテッド

2003-03-18 Publication of JP2003510349A publication Critical patent/JP2003510349A/ja

Status Pending legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 title claims abstract description 66
108090000623 proteins and genes Proteins 0.000 title abstract description 54
230000001105 regulatory effect Effects 0.000 title abstract description 10
101001072037 Homo sapiens cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Proteins 0.000 claims abstract description 131
102100036377 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Human genes 0.000 claims abstract description 122
208000023105 Huntington disease Diseases 0.000 claims abstract description 98
238000000034 method Methods 0.000 claims abstract description 86
241000124008 Mammalia Species 0.000 claims abstract description 8
230000014509 gene expression Effects 0.000 claims description 52
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 41
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 40
239000000203 mixture Substances 0.000 claims description 40
201000010099 disease Diseases 0.000 claims description 39
238000007901 in situ hybridization Methods 0.000 claims description 28
238000003752 polymerase chain reaction Methods 0.000 claims description 22
241001465754 Metazoa Species 0.000 claims description 16
230000000306 recurrent effect Effects 0.000 claims description 14
238000012360 testing method Methods 0.000 claims description 11
239000003795 chemical substances by application Substances 0.000 claims description 10
238000011282 treatment Methods 0.000 claims description 10
-1 Hexahydro-6- (5 -Benzofuranyl) -2-isopropyl-pyrazino [2 ', 1': 6,1] pyrido [3,4-b] indole-1,4-dione Chemical compound 0.000 claims description 9
239000003937 drug carrier Substances 0.000 claims description 7
230000009467 reduction Effects 0.000 claims description 7
HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical class O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 claims description 6
238000010367 cloning Methods 0.000 claims description 6
238000011830 transgenic mouse model Methods 0.000 claims description 6
102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 5
IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 claims description 5
229960002768 dipyridamole Drugs 0.000 claims description 5
239000004098 Tetracycline Chemical class 0.000 claims description 4
238000010171 animal model Methods 0.000 claims description 4
230000008569 process Effects 0.000 claims description 4
229960002180 tetracycline Drugs 0.000 claims description 4
229930101283 tetracycline Chemical class 0.000 claims description 4
235000019364 tetracycline Nutrition 0.000 claims description 4
150000003522 tetracyclines Chemical class 0.000 claims description 4
GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 claims description 3
SKLYHJGMOYNOJP-XMSQKQJNSA-N (6r,12ar)-6-(benzofuran-5-yl)-2-methyl-6,7,12,12a-tetrahydro-3h-pyrazino[1,2-b]$b-carboline-1,4-quinone Chemical compound C1=C2OC=CC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@H]3N2C(=O)CN(C3=O)C)=C1 SKLYHJGMOYNOJP-XMSQKQJNSA-N 0.000 claims description 3
MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical class O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 claims description 3
FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 claims description 3
229960002398 demeclocycline Drugs 0.000 claims description 3
229960005040 miconazole nitrate Drugs 0.000 claims description 3
ZHYZASJBUCBYSQ-DYESRHJHSA-N (6r,12ar)-6-(benzofuran-5-yl)-2,3,6,7,12,12a-hexahydropyrazino[1,2-b]$b-carboline-1,4-quinone Chemical compound C1=C2OC=CC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@H]3N2C(=O)CNC3=O)=C1 ZHYZASJBUCBYSQ-DYESRHJHSA-N 0.000 claims description 2
FFCZQVKVWGGQFB-UHFFFAOYSA-N 9h-pyrido[3,4-b]indole-1,4-dione Chemical compound N1C2=CC=CC=C2C2=C1C(=O)N=CC2=O FFCZQVKVWGGQFB-UHFFFAOYSA-N 0.000 claims description 2
RTRIXVOSRYRSBP-VXKWHMMOSA-N n-[(1s,2s)-2-phenylcyclopentyl]-1-azacyclotridecen-2-amine Chemical class N([C@H]1CCC[C@H]1C=1C=CC=CC=1)C1=NCCCCCCCCCCC1 RTRIXVOSRYRSBP-VXKWHMMOSA-N 0.000 claims description 2
238000002560 therapeutic procedure Methods 0.000 claims description 2
210000001577 neostriatum Anatomy 0.000 abstract description 39
230000005856 abnormality Effects 0.000 abstract description 10
238000012216 screening Methods 0.000 abstract description 5
108091033319 polynucleotide Proteins 0.000 description 81
102000040430 polynucleotide Human genes 0.000 description 81
239000002157 polynucleotide Substances 0.000 description 80
241000699670 Mus sp. Species 0.000 description 72
210000004027 cell Anatomy 0.000 description 61
108090000765 processed proteins & peptides Proteins 0.000 description 49
102000004196 processed proteins & peptides Human genes 0.000 description 46
239000000523 sample Substances 0.000 description 44
239000002773 nucleotide Substances 0.000 description 42
125000003729 nucleotide group Chemical group 0.000 description 42
229920001184 polypeptide Polymers 0.000 description 42
108020004414 DNA Proteins 0.000 description 41
210000004556 brain Anatomy 0.000 description 39
241000699666 Mus <mouse, genus> Species 0.000 description 37
239000013598 vector Substances 0.000 description 35
238000009396 hybridization Methods 0.000 description 34
108020004999 messenger RNA Proteins 0.000 description 33
102000004169 proteins and genes Human genes 0.000 description 31
150000007523 nucleic acids Chemical class 0.000 description 29
239000000047 product Substances 0.000 description 28
102000039446 nucleic acids Human genes 0.000 description 26
108020004707 nucleic acids Proteins 0.000 description 26
239000002299 complementary DNA Substances 0.000 description 25
241000282414 Homo sapiens Species 0.000 description 21
230000000694 effects Effects 0.000 description 20
239000012634 fragment Substances 0.000 description 20
239000005557 antagonist Substances 0.000 description 19
150000001413 amino acids Chemical class 0.000 description 18
230000000295 complement effect Effects 0.000 description 18
ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 17
108091028043 Nucleic acid sequence Proteins 0.000 description 16
241000700159 Rattus Species 0.000 description 16
208000024891 symptom Diseases 0.000 description 16
238000004458 analytical method Methods 0.000 description 14
238000002360 preparation method Methods 0.000 description 14
210000001519 tissue Anatomy 0.000 description 14
238000000636 Northern blotting Methods 0.000 description 13
108091034117 Oligonucleotide Proteins 0.000 description 13
108020005187 Oligonucleotide Probes Proteins 0.000 description 12
230000003321 amplification Effects 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 12
210000002569 neuron Anatomy 0.000 description 12
238000003199 nucleic acid amplification method Methods 0.000 description 12
239000002751 oligonucleotide probe Substances 0.000 description 12
230000002829 reductive effect Effects 0.000 description 12
108090000994 Catalytic RNA Proteins 0.000 description 11
102000053642 Catalytic RNA Human genes 0.000 description 11
210000001009 nucleus accumben Anatomy 0.000 description 11
108091092562 ribozyme Proteins 0.000 description 11
238000003556 assay Methods 0.000 description 10
238000011161 development Methods 0.000 description 10
238000009472 formulation Methods 0.000 description 10
239000013612 plasmid Substances 0.000 description 10
108091026890 Coding region Proteins 0.000 description 9
230000000692 anti-sense effect Effects 0.000 description 9
230000006727 cell loss Effects 0.000 description 9
239000000499 gel Substances 0.000 description 9
238000002347 injection Methods 0.000 description 9
239000007924 injection Substances 0.000 description 9
239000003550 marker Substances 0.000 description 9
210000004940 nucleus Anatomy 0.000 description 9
210000001550 testis Anatomy 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
239000000556 agonist Substances 0.000 description 8
238000009826 distribution Methods 0.000 description 8
230000006870 function Effects 0.000 description 8
208000014674 injury Diseases 0.000 description 8
239000000243 solution Substances 0.000 description 8
239000000758 substrate Substances 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
238000012546 transfer Methods 0.000 description 8
230000008733 trauma Effects 0.000 description 8
FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 7
108091033380 Coding strand Proteins 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
108010044467 Isoenzymes Proteins 0.000 description 7
208000006011 Stroke Diseases 0.000 description 7
230000009471 action Effects 0.000 description 7
230000008859 change Effects 0.000 description 7
239000003814 drug Substances 0.000 description 7
239000000839 emulsion Substances 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
230000001939 inductive effect Effects 0.000 description 7
229960004023 minocycline Drugs 0.000 description 7
239000008194 pharmaceutical composition Substances 0.000 description 7
230000000750 progressive effect Effects 0.000 description 7
238000013519 translation Methods 0.000 description 7
102220625006 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1_E10A_mutation Human genes 0.000 description 6
208000024827 Alzheimer disease Diseases 0.000 description 6
108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
208000012902 Nervous system disease Diseases 0.000 description 6
208000025966 Neurological disease Diseases 0.000 description 6
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
239000002775 capsule Substances 0.000 description 6
239000000969 carrier Substances 0.000 description 6
230000007423 decrease Effects 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
210000001739 intranuclear inclusion body Anatomy 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
239000002243 precursor Substances 0.000 description 6
238000000746 purification Methods 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
239000000126 substance Substances 0.000 description 6
230000009261 transgenic effect Effects 0.000 description 6
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
101100135859 Dictyostelium discoideum regA gene Proteins 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
241000282412 Homo Species 0.000 description 5
101100028926 Mus musculus Pde10a gene Proteins 0.000 description 5
208000018737 Parkinson disease Diseases 0.000 description 5
101100082606 Plasmodium falciparum (isolate 3D7) PDEbeta gene Proteins 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
101100135860 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PDE2 gene Proteins 0.000 description 5
238000002105 Southern blotting Methods 0.000 description 5
238000013459 approach Methods 0.000 description 5
230000004071 biological effect Effects 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
210000005013 brain tissue Anatomy 0.000 description 5
230000003197 catalytic effect Effects 0.000 description 5
229940079593 drug Drugs 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
238000002955 isolation Methods 0.000 description 5
239000002502 liposome Substances 0.000 description 5
239000000546 pharmaceutical excipient Substances 0.000 description 5
238000012545 processing Methods 0.000 description 5
201000000980 schizophrenia Diseases 0.000 description 5
238000012163 sequencing technique Methods 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
108020005345 3' Untranslated Regions Proteins 0.000 description 4
102000000584 Calmodulin Human genes 0.000 description 4
108010041952 Calmodulin Proteins 0.000 description 4
241000699660 Mus musculus Species 0.000 description 4
108010029485 Protein Isoforms Proteins 0.000 description 4
102000001708 Protein Isoforms Human genes 0.000 description 4
101100028927 Rattus norvegicus Pde10a gene Proteins 0.000 description 4
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
229920002472 Starch Polymers 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
206010044565 Tremor Diseases 0.000 description 4
230000001154 acute effect Effects 0.000 description 4
230000003281 allosteric effect Effects 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
125000004122 cyclic group Chemical group 0.000 description 4
230000007850 degeneration Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
230000002255 enzymatic effect Effects 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
108020001507 fusion proteins Proteins 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
210000005036 nerve Anatomy 0.000 description 4
239000002245 particle Substances 0.000 description 4
229920000155 polyglutamine Polymers 0.000 description 4
108010040003 polyglutamine Proteins 0.000 description 4
230000003252 repetitive effect Effects 0.000 description 4
238000011160 research Methods 0.000 description 4
229910052709 silver Inorganic materials 0.000 description 4
239000004332 silver Substances 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
238000013268 sustained release Methods 0.000 description 4
239000012730 sustained-release form Substances 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
102100024318 Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Human genes 0.000 description 3
108020004705 Codon Proteins 0.000 description 3
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
102000002494 Endoribonucleases Human genes 0.000 description 3
108010093099 Endoribonucleases Proteins 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
102000005720 Glutathione transferase Human genes 0.000 description 3
108010070675 Glutathione transferase Proteins 0.000 description 3
101001030705 Homo sapiens Huntingtin Proteins 0.000 description 3
101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
108700026244 Open Reading Frames Proteins 0.000 description 3
239000002202 Polyethylene glycol Substances 0.000 description 3
108700008625 Reporter Genes Proteins 0.000 description 3
102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 3
108700019146 Transgenes Proteins 0.000 description 3
241000700605 Viruses Species 0.000 description 3
208000028752 abnormal posture Diseases 0.000 description 3
238000007792 addition Methods 0.000 description 3
210000004227 basal ganglia Anatomy 0.000 description 3
102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
238000004590 computer program Methods 0.000 description 3
239000006184 cosolvent Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
239000008298 dragée Substances 0.000 description 3
238000000605 extraction Methods 0.000 description 3
230000004927 fusion Effects 0.000 description 3
102000054185 human HTT Human genes 0.000 description 3
239000008101 lactose Substances 0.000 description 3
239000003446 ligand Substances 0.000 description 3
238000007834 ligase chain reaction Methods 0.000 description 3
230000033001 locomotion Effects 0.000 description 3
230000007774 longterm Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
239000002609 medium Substances 0.000 description 3
238000000520 microinjection Methods 0.000 description 3
230000035772 mutation Effects 0.000 description 3
230000006764 neuronal dysfunction Effects 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
229920001223 polyethylene glycol Polymers 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
239000000843 powder Substances 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
230000028327 secretion Effects 0.000 description 3
239000000600 sorbitol Substances 0.000 description 3
235000010356 sorbitol Nutrition 0.000 description 3
241000894007 species Species 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
235000019698 starch Nutrition 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
238000001890 transfection Methods 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 2
OLSHGHDFGPOXHF-VXOKYEDTSA-N (3s,6r,12ar)-6-(benzofuran-5-yl)-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1,2-b]$b-carboline-1,4-quinone Chemical compound C1=C2OC=CC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@@H]3C(=O)N[C@H](C(N32)=O)C)=C1 OLSHGHDFGPOXHF-VXOKYEDTSA-N 0.000 description 2
QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
206010003694 Atrophy Diseases 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
102000018208 Cannabinoid Receptor Human genes 0.000 description 2
108050007331 Cannabinoid receptor Proteins 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
206010010904 Convulsion Diseases 0.000 description 2
101100243075 Cricetulus griseus PDE1B1 gene Proteins 0.000 description 2
102000001493 Cyclophilins Human genes 0.000 description 2
108010068682 Cyclophilins Proteins 0.000 description 2
102000016911 Deoxyribonucleases Human genes 0.000 description 2
108010053770 Deoxyribonucleases Proteins 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
101100296720 Dictyostelium discoideum Pde4 gene Proteins 0.000 description 2
101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 description 2
101100351286 Dictyostelium discoideum pdeE gene Proteins 0.000 description 2
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
101001117089 Drosophila melanogaster Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1 Proteins 0.000 description 2
208000012661 Dyskinesia Diseases 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
108091060211 Expressed sequence tag Proteins 0.000 description 2
108010074860 Factor Xa Proteins 0.000 description 2
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
108010024636 Glutathione Proteins 0.000 description 2
101001098858 Homo sapiens cGMP-dependent 3',5'-cyclic phosphodiesterase Proteins 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
102000003792 Metallothionein Human genes 0.000 description 2
108090000157 Metallothionein Proteins 0.000 description 2
208000016285 Movement disease Diseases 0.000 description 2
108700005084 Multigene Family Proteins 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
101150106395 PDE1B gene Proteins 0.000 description 2
101150098694 PDE5A gene Proteins 0.000 description 2
101100082610 Plasmodium falciparum (isolate 3D7) PDEdelta gene Proteins 0.000 description 2
208000028017 Psychotic disease Diseases 0.000 description 2
238000002123 RNA extraction Methods 0.000 description 2
239000013614 RNA sample Substances 0.000 description 2
229940124639 Selective inhibitor Drugs 0.000 description 2
241000251131 Sphyrna Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
108090000190 Thrombin Proteins 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000004913 activation Effects 0.000 description 2
239000012190 activator Substances 0.000 description 2
239000013543 active substance Substances 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
230000004075 alteration Effects 0.000 description 2
150000001450 anions Chemical class 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000037444 atrophy Effects 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
230000006399 behavior Effects 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
102100038953 cGMP-dependent 3',5'-cyclic phosphodiesterase Human genes 0.000 description 2
239000011575 calcium Substances 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
210000001159 caudate nucleus Anatomy 0.000 description 2
108091092328 cellular RNA Proteins 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
229930003836 cresol Natural products 0.000 description 2
230000006735 deficit Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
235000014113 dietary fatty acids Nutrition 0.000 description 2
239000000194 fatty acid Substances 0.000 description 2
229930195729 fatty acid Natural products 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
238000005194 fractionation Methods 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
229960003180 glutathione Drugs 0.000 description 2
235000011187 glycerol Nutrition 0.000 description 2
229960003878 haloperidol Drugs 0.000 description 2
102000054918 human PDE10A Human genes 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000010354 integration Effects 0.000 description 2
230000003993 interaction Effects 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
230000000670 limiting effect Effects 0.000 description 2
230000004807 localization Effects 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
230000001404 mediated effect Effects 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
238000001000 micrograph Methods 0.000 description 2
230000037230 mobility Effects 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
230000000926 neurological effect Effects 0.000 description 2
239000003791 organic solvent mixture Substances 0.000 description 2
101150037969 pde-6 gene Proteins 0.000 description 2
210000002637 putamen Anatomy 0.000 description 2
FTSUPYGMFAPCFZ-ZWNOBZJWSA-N quinpirole Chemical compound C([C@H]1CCCN([C@@H]1C1)CCC)C2=C1C=NN2 FTSUPYGMFAPCFZ-ZWNOBZJWSA-N 0.000 description 2
229950001037 quinpirole Drugs 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
230000004044 response Effects 0.000 description 2
238000003757 reverse transcription PCR Methods 0.000 description 2
102220240796 rs553605556 Human genes 0.000 description 2
230000007017 scission Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
239000007787 solid Substances 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
239000008107 starch Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
235000012222 talc Nutrition 0.000 description 2
230000002123 temporal effect Effects 0.000 description 2
229940124597 therapeutic agent Drugs 0.000 description 2
229960004072 thrombin Drugs 0.000 description 2
230000005030 transcription termination Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
241001430294 unidentified retrovirus Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
238000005406 washing Methods 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
ZGIYAMUXBBXMTB-NCNFXNTHSA-N (3s,6r,12ar)-6-(benzofuran-5-yl)-2,3-dimethyl-6,7,12,12a-tetrahydro-3h-pyrazino[1,2-b]$b-carboline-1,4-quinone Chemical compound C1=C2OC=CC2=CC([C@@H]2C3=C(C4=CC=CC=C4N3)C[C@@H]3C(=O)N(C)[C@H](C(N32)=O)C)=C1 ZGIYAMUXBBXMTB-NCNFXNTHSA-N 0.000 description 1
101150084750 1 gene Proteins 0.000 description 1
DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
101150072531 10 gene Proteins 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
108010054479 3',5'-Cyclic-AMP Phosphodiesterases Proteins 0.000 description 1
102000001707 3',5'-Cyclic-AMP Phosphodiesterases Human genes 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
108020003589 5' Untranslated Regions Proteins 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
208000035657 Abasia Diseases 0.000 description 1
206010000117 Abnormal behaviour Diseases 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
102000012440 Acetylcholinesterase Human genes 0.000 description 1
108010022752 Acetylcholinesterase Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
206010001488 Aggression Diseases 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
108020004491 Antisense DNA Proteins 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
241000228212 Aspergillus Species 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
108010077805 Bacterial Proteins Proteins 0.000 description 1
102100026189 Beta-galactosidase Human genes 0.000 description 1
206010006100 Bradykinesia Diseases 0.000 description 1
208000014644 Brain disease Diseases 0.000 description 1
241000244202 Caenorhabditis Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
102100033029 Carbonic anhydrase-related protein 11 Human genes 0.000 description 1
206010008748 Chorea Diseases 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
229940121946 Cyclic AMP inhibitor Drugs 0.000 description 1
101150097493 D gene Proteins 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
230000007023 DNA restriction-modification system Effects 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
239000004338 Dichlorodifluoromethane Substances 0.000 description 1
241000224495 Dictyostelium Species 0.000 description 1
108010090047 Dopamine and cAMP-Regulated Phosphoprotein 32 Proteins 0.000 description 1
102000012749 Dopamine and cAMP-Regulated Phosphoprotein 32 Human genes 0.000 description 1
208000014094 Dystonic disease Diseases 0.000 description 1
241000792859 Enema Species 0.000 description 1
241000282324 Felis Species 0.000 description 1
102000012074 GAF domains Human genes 0.000 description 1
108050002598 GAF domains Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102100036738 Guanine nucleotide-binding protein subunit alpha-11 Human genes 0.000 description 1
108010078321 Guanylate Cyclase Proteins 0.000 description 1
102000014469 Guanylate cyclase Human genes 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
108090001102 Hammerhead ribozyme Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101001117099 Homo sapiens Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B Proteins 0.000 description 1
101000867841 Homo sapiens Carbonic anhydrase-related protein 11 Proteins 0.000 description 1
101001041589 Homo sapiens Defensin-5 Proteins 0.000 description 1
101100283445 Homo sapiens GNA11 gene Proteins 0.000 description 1
101001075218 Homo sapiens Gastrokine-1 Proteins 0.000 description 1
101000899255 Homo sapiens Histone deacetylase 5 Proteins 0.000 description 1
101000609947 Homo sapiens Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Proteins 0.000 description 1
101000988412 Homo sapiens cGMP-specific 3',5'-cyclic phosphodiesterase Proteins 0.000 description 1
102000016252 Huntingtin Human genes 0.000 description 1
108050004784 Huntingtin Proteins 0.000 description 1
208000006083 Hypokinesia Diseases 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
208000009668 Neurobehavioral Manifestations Diseases 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
101100271190 Plasmodium falciparum (isolate 3D7) ATAT gene Proteins 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
206010071390 Resting tremor Diseases 0.000 description 1
102100039177 Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha Human genes 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
241001486234 Sciota Species 0.000 description 1
108091081021 Sense strand Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
241000256248 Spodoptera Species 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
241000187747 Streptomyces Species 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
241000248384 Tetrahymena thermophila Species 0.000 description 1
241000589596 Thermus Species 0.000 description 1
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
102000004338 Transferrin Human genes 0.000 description 1
108090000901 Transferrin Proteins 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
244000042312 Wisteria floribunda Species 0.000 description 1
235000010724 Wisteria floribunda Nutrition 0.000 description 1
ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
229940022698 acetylcholinesterase Drugs 0.000 description 1
150000008043 acidic salts Chemical class 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
229940040563 agaric acid Drugs 0.000 description 1
230000016571 aggressive behavior Effects 0.000 description 1
208000012761 aggressive behavior Diseases 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
238000002266 amputation Methods 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000005571 anion exchange chromatography Methods 0.000 description 1
239000003957 anion exchange resin Substances 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000000561 anti-psychotic effect Effects 0.000 description 1
239000003816 antisense DNA Substances 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
210000000436 anus Anatomy 0.000 description 1
210000003433 aortic smooth muscle cell Anatomy 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
238000000211 autoradiogram Methods 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000008827 biological function Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000003925 brain function Effects 0.000 description 1
210000000133 brain stem Anatomy 0.000 description 1
238000000339 bright-field microscopy Methods 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
230000003491 cAMP production Effects 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
229960004424 carbon dioxide Drugs 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
238000005277 cation exchange chromatography Methods 0.000 description 1
239000003729 cation exchange resin Substances 0.000 description 1
229940023913 cation exchange resins Drugs 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000030833 cell death Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000002421 cell wall Anatomy 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000005754 cellular signaling Effects 0.000 description 1
210000001638 cerebellum Anatomy 0.000 description 1
230000003727 cerebral blood flow Effects 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
210000004720 cerebrum Anatomy 0.000 description 1
208000012601 choreatic disease Diseases 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
230000001149 cognitive effect Effects 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
238000005094 computer simulation Methods 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
210000000877 corpus callosum Anatomy 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
210000005257 cortical tissue Anatomy 0.000 description 1
201000003740 cowpox Diseases 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
239000008380 degradant Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
229940042935 dichlorodifluoromethane Drugs 0.000 description 1
229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000007876 drug discovery Methods 0.000 description 1
238000007878 drug screening assay Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000008482 dysregulation Effects 0.000 description 1
208000010118 dystonia Diseases 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000002996 emotional effect Effects 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
239000000469 ethanolic extract Substances 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000001508 eye Anatomy 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000010685 fatty oil Substances 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000013467 fragmentation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
210000000609 ganglia Anatomy 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000003205 genotyping method Methods 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
239000008202 granule composition Substances 0.000 description 1
238000000227 grinding Methods 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000002216 heart Anatomy 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000012188 high-throughput screening assay Methods 0.000 description 1
210000001320 hippocampus Anatomy 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
102000048466 human DEFA5 Human genes 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
229920001600 hydrophobic polymer Polymers 0.000 description 1
238000012872 hydroxylapatite chromatography Methods 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
238000005286 illumination Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000002513 implantation Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000001802 infusion Methods 0.000 description 1
208000030309 inherited neurodegenerative disease Diseases 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
239000004922 lacquer Substances 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000002523 lectin Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000001259 mesencephalon Anatomy 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004973 motor coordination Effects 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
230000004770 neurodegeneration Effects 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
230000016273 neuron death Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
108091027963 non-coding RNA Proteins 0.000 description 1
102000042567 non-coding RNA Human genes 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 description 1
229960005017 olanzapine Drugs 0.000 description 1
210000001010 olfactory tubercle Anatomy 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
RUUFMHUAHUPZSS-UHFFFAOYSA-N oxido-oxo-sulfinophosphanium Chemical compound P(=O)(=O)S(=O)O RUUFMHUAHUPZSS-UHFFFAOYSA-N 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000037361 pathway Effects 0.000 description 1
229960001412 pentobarbital Drugs 0.000 description 1
WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
230000008447 perception Effects 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000012071 phase Substances 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
229940080469 phosphocellulose Drugs 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
125000001863 phosphorothioyl group Chemical group *P(*)(*)=S 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
230000000379 polymerizing effect Effects 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000007425 progressive decline Effects 0.000 description 1
210000001176 projection neuron Anatomy 0.000 description 1
239000003380 propellant Substances 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
108010043671 prostatic acid phosphatase Proteins 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
230000007065 protein hydrolysis Effects 0.000 description 1
230000029983 protein stabilization Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
239000003586 protic polar solvent Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000002601 radiography Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
238000005185 salting out Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
JOSMPBVYYKRYLG-QWHCGFSZSA-N sch51866 Chemical compound N1([C@@H]2CCC[C@@H]2N=C1N(C(C=1N2)=O)C)C=1N=C2CC1=CC=C(C(F)(F)F)C=C1 JOSMPBVYYKRYLG-QWHCGFSZSA-N 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
238000004904 shortening Methods 0.000 description 1
238000002603 single-photon emission computed tomography Methods 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
239000002002 slurry Substances 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000007901 soft capsule Substances 0.000 description 1
239000012439 solid excipient Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
239000010936 titanium Substances 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
239000012581 transferrin Substances 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
229940029284 trichlorofluoromethane Drugs 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
230000002861 ventricular Effects 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
238000012800 visualization Methods 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
210000005253 yeast cell Anatomy 0.000 description 1